The federal court ruling regarding a dispute under the No Surprises Act (NSA) has been subject to debate throughout the healthcare and insurance sectors. Although the decision was based primarily on the extent of judicial review available for independent dispute resolution (IDR) determinations, its impact extends far beyond the context of this particular case. This ruling signifies a much larger truth for insurers, self-insured employers, TPAs and stop-loss carriers. The next stage of the NSA will be shaped by risk management strategy.
When Congress created the NSA, the intention was to protect patients from receiving unexpected medical bills while creating a method for both providers and payers to resolve payment disputes through a formalized process. However, the federal IDR process has developed into a large-volume operational process that currently affects a payer's forecasting of expenses, compliance responsibilities, potential liability due to litigation and resource usage.
Since dispute volumes continue to grow nationwide, organizations can no longer consider IDR solely as a claims-related function.
A System Developing Scale
The federal IDR process, originally designed as a mechanism for resolving select payment disagreements, has significantly exceeded usage estimates, developing into a national system processing 5.1 million disputes since its inception. The unexpected usage introduces additional risk concerns that include new administrative burdens, such as increased costs associated with managing cases and maintaining consistency within documentation, eligibility reviews and reimbursement strategies.
Consequently, participants in the IDR system have become increasingly sophisticated. As such, there exists greater amounts of data supporting each dispute filed. Filing strategies are advancing and parties are gaining experience and familiarity with the procedures and the decisionmakers. Therefore, the amount of risk involved with each IDR determination extends beyond the dollar value of each determination. Each determination will potentially influence broader reimbursement trends, reserve levels and future dispute activities.
For insurance organizations, the question goes beyond whether IDR will be a permanent feature of the healthcare landscape and shifts focus to how they will manage the associated risks.
Litigation Uncertainty Creates Another Layered Problem
The federal court decision underscores the boundaries of judicial review under the NSA. While the ruling suggests a limited role for courts in revisiting certain aspects of IDR determinations, similar disputes are continuing in various federal courts across multiple jurisdictions. Future appeals and litigation may shape the interpretation and application of judicial review under the law.
For insurers and plan sponsors, this creates a real-world concern. Traditionally, litigation provided an opportunity to clarify the applicable laws and determine whether actions were improper. Without a defined level of judicial intervention, it is more difficult for organizations to predict outcomes and assess their legal exposure.
This does not suggest litigation will cease to exist within the IDR landscape. Instead, it indicates organizations need to plan for a time when litigation results may differ across jurisdictions and unanswered legal issues may persist for lengthy periods. Under such conditions, reliance on courts to resolve operational challenges becomes increasingly impractical.
The ruling also raises broader questions regarding oversight. As dispute volume continues to grow, confidence in the long-term integrity of the IDR process depends upon consistent eligibility standards, transparent administration and meaningful accountability mechanisms. If judicial review is limited, the importance of getting those processes right at the administrative level increases substantially.
The Paradigm Shift from Reactive to Proactive Risk Management
As litigation pathways become less predictable, risk management must begin looking forward. Many organizations historically regarded payment disputes as independent events that occurred individually and therefore could be resolved post-dispute. Such a philosophy is becoming less viable as disputes are occurring in the thousands and each IDR determination can have cumulative financial implications.
A more sustainable model of risk management begins prior to arbitration. Organizations should adopt clear governance models for eligibility review, reimbursement methodology and dispute documentation. Similarly, internal processes should ensure that positions taken during dispute resolution processes are supported by consistent data, defendable payment rationale and adequate documentation.
Equally important is identifying patterns, such as large volume filing activity, frequently disputed categories and geographic trends, which provides useful information relative to future exposure. Organizations that understand where future exposures may occur are better able to allocate resources and respond proactively. The objective of this paradigm shift is not merely winning individual disputes but rather developing an architecture that allows for consistent decision making within increasing complexity.
IDR Has Become an Enterprise Risk Issue
Perhaps the most critical takeaway from recent developments is that IDR cannot be assessed solely from a claims administration perspective. The financial impacts relate to budgeting, reserving and managing health care related costs. Operational impacts relate to staffing, workflow and administrative efficiencies. Legal impacts relate to compliance with regulations, dispute resolution practices and litigation strategy. Collectively these factors raise IDR from a reimbursement issue to an enterprise-wide risk management issue.
As such, greater organizational involvement is required. Allowing IDR to be managed from an enterprise-risk perspective involves collaboration among all relevant departments including legal teams, claims professionals, financial leadership and executive-level stakeholders.
If organizations continue to treat IDR as a normal administrative process, they may find themselves responding reactively to emerging problems. Organizations that integrate IDR into their overall risk management program will be best situated to manage future uncertainty.
Looking Forward
This federal court decision may ultimately be remembered more for what it reveals about the evolving nature of the IDR system than for any immediate legal ramifications. As IDR continues to scale nationally, the healthcare sector is entering a period where operational discipline, data-based oversight and proactive governance will become increasingly essential.
Regardless of how future courts choose to interpret the scope of judicial review under the NSA, one fact appears evident. Those organizations most likely to successfully navigate this evolving regulatory landscape will not be those who focus on individual IDR disputes. Rather, those who recognize IDR as a strategic risk management challenge and invest in the infrastructure, expertise and oversight needed to address it.
